Skip to content
healthcare.dev
Get a free key

Dapagliflozin

NDC 42571-317, Dapagliflozin, tablet, from Micro Labs Limited.

Product NDC
42571-317
Status
Listed
Labeler
Micro Labs Limited
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA211467
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/42571-317 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • DAPAGLIFLOZIN5 mg/1

Pharmacologic classes

Sodium-Glucose Cotransporter 2 Inhibitor [EPC]; Sodium-Glucose Transporter 2 Inhibitors [MoA]

Package NDCNDC-11Package
42571-317-10425710317101000 TABLET in 1 BOTTLE (42571-317-10)
42571-317-304257103173030 TABLET in 1 BOTTLE (42571-317-30)
42571-317-904257103179090 TABLET in 1 BOTTLE (42571-317-90)

Linked data

RxNorm, label and prices

RxNorm concepts

RxNorm links no concept to this product's packages.

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/5dc0e9df-3b45-4469-93fe-3d2eddbfe2b7

Use it

Look up 42571-317 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/42571-317 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 42571-317. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.